Loading patent…
AssigneeShin-il Pharmaceutical Co., Ltd.
InventorsJeong Min Lee, Jee Hun Park, Jaehoon You, Kyoungmi Noh, Sena Kim, Eunsook Ahn, Young Suk Lee, Young June Lee, Wahn Soo Choi
Estimating the term…
The present invention relates to a pharmaceutical composition for treating and preventing inflammatory diseases comprising an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient and a method for producing the fraction. More particularly, the present invention relates to a composition for preventing and treating inflammatory diseases comprising an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, in which the extract of Trachelospermi caulis is refined and concentrated to contain 0.05˜12% by weight of arctigenin as an index material, and a method for producing the fraction.
A composition for treating inflammatory diseases, comprising an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, wherein the extract of Trachelospermi caulis contains 0.05 to 12% by weight of arctigenin as an index material and 6 to 20% by weight of arctiin.
A method for producing an ethyl acetate fraction of dried extract of Trachelospermi caulis, comprising the steps of:
A method of treating inflammatory diseases comprising administering to a subject an effective amount of a composition comprising an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, wherein the extract of Trachelospermi caulis contains 0.05 to 12% by weight of arctigenin as an index material.
Dependencies are inferred from the claim text.